Intra-Cellular Therapies Inc (ITCI)
85.05
+1.05
(+1.25%)
USD |
NASDAQ |
Dec 24, 12:45
Intra-Cellular Therapies Market Cap: 9.017B for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 151.37B |
NovaBay Pharmaceuticals Inc | 2.625M |
Palatin Technologies Inc | 18.75M |
iBio Inc | 22.23M |
Theriva Biologics Inc | 4.758M |
Market Cap Related Metrics
PS Ratio | 13.97 |
Price to Book Value | 7.876 |
Price | 85.05 |
Earnings Yield | -1.02% |